Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection

M. Razavizadeh, A. Arj, M. Madani, H. Gilassi

. 2020 ; 63 (4) : 183-187.

Jazyk angličtina Země Česko

Typ dokumentu klinické zkoušky, srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21023700

BACKGROUND: The aim of this study was comparison the effectiveness of sequential and standard quadruple therapy on eradication of H. pylori infection. METHODS: This clinical trial study was conducted on 160 patients with dyspepsia or gastroduodenal ulcer. Patients were randomly divided into two groups. Group A (standard regimen) received omeprazole, amoxicillin, clarithromycin and bismuth subcitrate for 2 weeks. Group B (sequential regimen) received omeprazole and amoxicillin in 5 days and omeprazole, tinidazole and levofloxacin in 5 days. After the end of treatment regimens, 20 mg omeprazole was administered twice daily for 3 weeks. H. pylori eradication was assessed 2 months after antibiotic treatment via fecal antigen. RESULTS: Frequency of H. pylori eradication in group A and B was observed in 55 (68.8%) and 63 patients (78.8%), respectively. No significant difference was seen between two groups, regarding H. pylori eradication (p = 0.15). The most common side effects in group A, B were bitterness of mouth (63.8%) and nausea (16.2%), respectively (p H. pylori infection, higher rate of H. pylori eradication was seen in group B than group A. Thus, sequential regimen was a more appropriate regimen with fewer complications.

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21023700
003      
CZ-PrNML
005      
20211104134122.0
007      
ta
008      
211005s2020 xr f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2020.61 $2 doi
035    __
$a (PubMed)33355079
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Razavizadeh, Mohsen $u Department of Internal Medicine, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
245    10
$a Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection / $c M. Razavizadeh, A. Arj, M. Madani, H. Gilassi
504    __
$a Literatura
520    9_
$a BACKGROUND: The aim of this study was comparison the effectiveness of sequential and standard quadruple therapy on eradication of H. pylori infection. METHODS: This clinical trial study was conducted on 160 patients with dyspepsia or gastroduodenal ulcer. Patients were randomly divided into two groups. Group A (standard regimen) received omeprazole, amoxicillin, clarithromycin and bismuth subcitrate for 2 weeks. Group B (sequential regimen) received omeprazole and amoxicillin in 5 days and omeprazole, tinidazole and levofloxacin in 5 days. After the end of treatment regimens, 20 mg omeprazole was administered twice daily for 3 weeks. H. pylori eradication was assessed 2 months after antibiotic treatment via fecal antigen. RESULTS: Frequency of H. pylori eradication in group A and B was observed in 55 (68.8%) and 63 patients (78.8%), respectively. No significant difference was seen between two groups, regarding H. pylori eradication (p = 0.15). The most common side effects in group A, B were bitterness of mouth (63.8%) and nausea (16.2%), respectively (p H. pylori infection, higher rate of H. pylori eradication was seen in group B than group A. Thus, sequential regimen was a more appropriate regimen with fewer complications.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a amoxicilin $x aplikace a dávkování $7 D000658
650    _2
$a klarithromycin $x aplikace a dávkování $7 D017291
650    _2
$a kombinovaná farmakoterapie $7 D004359
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a infekce vyvolané Helicobacter pylori $x farmakoterapie $7 D016481
650    _2
$a Helicobacter pylori $7 D016480
650    _2
$a lidé $7 D006801
650    _2
$a levofloxacin $x aplikace a dávkování $7 D064704
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a omeprazol $x aplikace a dávkování $7 D009853
650    _2
$a organokovové sloučeniny $x aplikace a dávkování $7 D009942
650    _2
$a tinidazol $x aplikace a dávkování $7 D014011
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Arj, Abbas $u Department of Internal Medicine, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
700    1_
$a Madani, Maryam $u Department of Internal Medicine, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
700    1_
$a Gilassi, Hamidreza $u Department of Internal Medicine, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
773    0_
$w MED00010947 $t Acta Medica (Hradec Kralove) $x 1805-9694 $g Roč. 63, č. 4 (2020), s. 183-187
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33355079 $y Pubmed
910    __
$a ABA008 $b A 3077 $c 1072 $y p $z 0
990    __
$a 20211005 $b ABA008
991    __
$a 20211008111451 $b ABA008
999    __
$a ok $b bmc $g 1718888 $s 1144194
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 63 $c 4 $d 183-187 $i 1805-9694 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
LZP    __
$b NLK118 $a Pubmed-20211005

Najít záznam

Citační ukazatele

Možnosti archivace